Evidence map›Paper›PMID 32982754›Full record

ArticleFrontiers in pharmacology2020

Protective Effects of

Yueyue Shi, Chongmei Tian, Xinfen Yu, Yuejuan Fang, Xinyu Zhao, Xiaoxi Zhang, Daozong Xia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Investigation of the molecular mechanism ofFrontiers in pharmacology · 2024
    Article
  11. Polysaccharide fromNutrients · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Drug design, development and therapy · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yueyue ShiCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Chongmei TianCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xinfen YuCenter of Health Laboratory Technology, Hangzhou Center for Disease Control and Prevention, Hangzhou, China.
Yuejuan FangCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xinyu ZhaoCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xiaoxi ZhangCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Daozong XiaCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zhejiang Chinese Medical University · CNHangzhou Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lead (Pb) is an important environmental pollutant. Oxidative stress and the inflammatory response have been postulated as mechanisms involved in lead-induced renal damage.

Indexed as

apoptosisinflammatory pathwaylead-induced nephrotoxicityoxidative stressSmilax glabra Roxb.

Identifiers

PMID32982754
PMCPMC7493636
OpenAlexW3082491060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.